1. Bentwich, Z., Douglas, S. D., Siegal, F. P., and Kunkel, H. G., 1973, Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction, Clin. Immunol. Immunopathol. 1:511–522.
2. Birr, C, and Stollenwerk, U., 1979, Synthesis of thymosin 03b11, a polypeptide of the thymus, Angew.Chem. 91:422.
3. Cohen, M. H., Chretien, P. A., Ihle, D. C., Fossieck, B. E., Makuch, R., Bunn, P. A., Johnston, A. V., Shackney, S. E., Mathews, M. J., Lipson, S. D., Kenady, D. E., and Minna, J. D., 1979, Thymosin fraction V and intensive combination chemotherapy prolonging the survival of patients with small-cell lung cancer, J. Am. Med. Assoc. 241:1813–1815.
4. Dardenne, M., and Bach, J.-F., 1973, Studies on thymus products: Mofidifcation of rosette-forming cells by thymic extracts. I. Determination of the target RFC subpopulation, Immunology 25:343–352.
5. Dillman, R. O., Beauregard, J. C., Medelsohn, J., Green, M. R., Howell, S. B., and Royston, I., 1982, Phase I trial of thymosin fraction 5 and thymosin α1, J. Biol. Resp. Mod. 1:35–42.